Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-041515)

Filing Details

Accession Number:: 0001209191-13-041515
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2013-08-20 14:56:12
Reporting Period:: 2013-01-25

Filing Date:: 2013-08-20
Accepted Time:: 2013-08-20 14:56:12
Original Submission Date:: 2013-01-29
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1262104	Mei Pharma Inc.	MEIP	Pharmaceutical Preparations (2834)	510407811

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1533340	Iii V. Charles Baltic	C/O Mei Pharma, Inc 11975 El Camino Real, Suite 101 San Diego CA 92130		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.00000002 Per Share	Acquisiton	2013-01-25	4,200	$6.25	9,300	No	4	P	Direct
Common Stock, Par Value $0.00000002 Per Share	Acquisiton	2013-01-25	80	$5.75	9,380	No	4	P	Direct
Common Stock, Par Value $0.00000002 Per Share	Acquisiton	2013-01-25	5,920	$5.90	15,300	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.00000002 Per Share	1,700	Indirect	By Spouse

Footnotes

This amendment is being filed to reflect the number of shares held indirectly by the reporting person, which were originally reported on an aggregate basis with the number of shares reported as held directly by the reporting person.